Cytovale | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Cytovale is a medical diagnostics company based in South San Francisco, focused on developing rapid diagnostic technologies for fast-moving and immune-mediated diseases, particularly early sepsis detection. Founded in 2013, the company emerged from academic research that began in 2007. Cytovale combines the expertise of biologists, data scientists, and engineers to create innovative diagnostic tools that analyze the innate immune response.

The flagship product, IntelliSep, is an FDA-cleared rapid sepsis diagnostic test that utilizes advanced microfluidics and machine learning to analyze white blood cells from a standard blood draw. This test measures immune system dysregulation and can stratify a patient’s risk of sepsis in about eight to ten minutes, enabling timely and accurate detection in emergency departments. The technology platform, Cytovale System, further enhances this capability by isolating, imaging, and analyzing cells to assess immune activation. The company aims to expand its technology to other immune-related diagnostic applications in the future.